• Publications
  • Influence
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
This document is an international evidence-based guideline on the diagnosis and management of idiopathic pulmonary fibrosis, and is a collaborative effort of the American Thoracic Society, theExpand
  • 3,559
  • 228
  • PDF
An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.
BACKGROUND In 2002 the American Thoracic Society/European Respiratory Society (ATS/ERS) classification of idiopathic interstitial pneumonias (IIPs) defined seven specific entities, and providedExpand
  • 1,707
  • 109
  • PDF
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
BACKGROUND Idiopathic pulmonary fibrosis is a progressive and fatal lung disease with inevitable loss of lung function. The CAPACITY programme (studies 004 and 006) was designed to confirm theExpand
  • 1,270
  • 66
  • PDF
Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis.
BACKGROUND Idiopathic pulmonary fibrosis is a progressive lung disease with a high mortality rate. Because the signaling pathways activated by several tyrosine kinase receptors have been shown to beExpand
  • 717
  • 40
  • PDF
European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis
Lymphangioleiomyomatosis (LAM) is a rare lung disease, which occurs sporadically or in association with the genetic disease tuberous sclerosis complex (TSC) 1, 2. Sporadic LAM affects ∼1 in 400,000Expand
  • 332
  • 39
  • PDF
High-dose acetylcysteine in idiopathic pulmonary fibrosis.
BACKGROUND Idiopathic pulmonary fibrosis is a chronic progressive disorder with a poor prognosis. METHODS We conducted a double-blind, randomized, placebo-controlled multicenter study that assessedExpand
  • 857
  • 26
  • PDF
Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections.
We present a rigorously validated and highly sensitive confirmatory real-time RT-PCR assay (1A assay) that can be used in combination with the previously reported upE assay. Two additional RT-PCRExpand
  • 295
  • 25
  • PDF
An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease.
  • K. Meyer, G. Raghu, +12 authors B. Wood
  • Medicine
  • American journal of respiratory and critical care…
  • 14 December 2012
BACKGROUND The clinical utility of bronchoalveolar lavage fluid (BAL) cell analysis for the diagnosis and management of patients with interstitial lung disease (ILD) has been a subject of debate andExpand
  • 465
  • 24
ATS/ERS/WASOG statement on sarcoidosis
The first international consensus statement on sarcoidosis is currently being copublished in the journals of the American Thoracic Society (ATS) and the World Association for Sarcoidosis and OtherExpand
  • 326
  • 21
  • PDF